Infantile hemangioma of the upper eyelid in one very and two extremely preterm infants

INFANTILNI HEMANGIOMI KAPKA

  • Milica Žeravica University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Aleksandra Matić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Milan Matić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Miloš Pajić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Sonja Prćić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Keywords: drug therapy, eyelids, hemangioma, infant, extremely premature, infant, premature, propranolol

Abstract


Introduction. Infantile hemangiomas (IHs) are the most common vascular tumors of infancy whose frequency increases with decreasing gestational age. Although rare, periorbital IHs (PIHs) have a high complication rate, with a substantial risk of impaired vision and aesthetic consequences. Because they are considered high-risk IH, such patients must be treated. In the available literature, there is little information about the treatment of IHs in very and extremely preterm newborns and infants. Case report. We present three male infants (one very and two extremely prematurely born) with PIHs involving the upper eyelid. In all three cases, IHs were solitary but with different subtypes according to soft-tissue depth (superficial, combined, deep). No additional congenital anomalies were found in any of these cases. An individualized approach to the management of each patient was applied. All infants were treated with oral administration of propranolol, with careful monitoring for potential side effects of the drug and adjustment of treatment, following their eventual occurrence. The introduction of oral propranolol was carried out in a hospital setting, with a gradual increase of the drug dose until the target dose was reached. Conclusion. In the case of PIH, an ophthalmologist is an inevitable part of the medical team. Very and extremely preterm infants are already under the supervision of an ophthalmologist due to mandatory screening for retinopathy of prematurity; however, if they also have PIHs, monitoring must be particularly detailed and long-lasting.

References

Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, et al. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics 2019; 143(1): e20183475.

Alniemi ST, Griepentrog GJ, Diehl N, Mohney BG. Incidence and clinical characteristics of periocular infantile hemangiomas. Arch Ophthalmol 2012; 130(7): 889–93.

Samuelov L, Kinori M, Rychlik K, Konanur M, Chamlin SL, Rah-mani B, et al. Risk factors for ocular complications in periocu-lar infantile hemangiomas. Pediatr Dermatol 2018; 35(4): 458–62.

Martin JM, Sanchez S, González V, Cordero P, Ramon D. Infan-tile hemangiomas with minimal or arrested growth: A retro-spective case series. Pediatr Dermatol 2019; 36(1): 125–31.

Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118(3): 882–7.

Harter N, Mancini AJ. Diagnosis and management of infantile hemangiomas in the neonate. Pediatr Clin North Am 2019; 66(2): 437–59.

O TM, Ceisler E, Broude C, Chan K, Pacicco L, Fay A, et al. Dis-tribution and Clinical Characteristics of Periorbital Infantile Hemangiomas. Facial Plast Surg Aesthet Med 2023; 25(2): 172–8.

Kurachi A, Ozaki M, Ihara A, Eto H, Takushima A. Eyelid Thread-lifting Treatment for Periocular Infantile Hemangioma in an Extremely Premature Low-birth-weight Infant. Plast Reconstr Surg Glob Open 2019; 7(8): e2373.

Cheng CE, Friedlander SF. Infantile hemangiomas, complica-tions and treatments. Semin Cutan Med Surg 2016; 35(3): 108–16.

Soliman YS, Khachemoune A. Infantile hemangiomas: our cur-rent understanding and treatment options. Dermatol Online J 2018; 24(9): 13030/qt5jt8q9km.

O'Connor AR, Wilson CM, Fielder AR. Ophthalmological prob-lems associated with preterm birth. Eye (Lond) 2007; 21(10): 1254–60.

Haggstrom AN, Baselga E, Chamlin SL, Drolet BA, Garzon MC, Holland KE, et al. Localized infantile hemangiomas of the face and scalp: Predilection for the midline and periorbital and pe-rioral skin. Pediatr Dermatol 2018; 35(6): 774–9.

Droitcourt C, Kerbrat S, Rault C, Botrel MA, Happe A, Gar-lantezec R, et al. Safety of Oral Propranolol for Infantile He-mangioma. Pediatrics 2018; 141(6): e20173783.

Chen WL, Lan YQ, Hong L, Dong XY. Comprehensive Man-agement of Infantile Hemangiomas Involving the Periorbital Region. Ann Plast Surg 2022; 89(4): 391–4.

Published
2023/12/29
Section
Case report